Rebel Medicine develops medicine for opioid-free pain management.
Rebel Medicine has raised $6.0M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Rebel Medicine's investors include Prosperity Solutions Capital, Cantina Angels, Sorenson Impact, Central Texas Angel Network, Altitude Lab.
Rebel Medicine is headquartered in Salt Lake City, United States.
Rebel Medicine develops medicine for opioid-free pain management.
Rebel Medicine is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rebel Medicine — Funding & Investors." VCBacked, February 6, 2025, https://www.vcbacked.co/company/rebel-medicine. Accessed September 14, 2026.
VCBacked. (2025). Rebel Medicine — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/rebel-medicine
{{cite web |title=Rebel Medicine — Funding & Investors |url=https://www.vcbacked.co/company/rebel-medicine |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated